Additional information for the event reported on this date: the infusate was carmustine.The report stated that the alleged occlusion occurred after the drug had completed about half to three quarters of infusion.As a result, the bag was disconnected and the pharmacy re-calibrated the amount remaining to be infused and set up a new bag.The report stated all new tubing was sut up and the remainder of the drug was administered without complications.Reference manufacturer report numbers: 1649914-2015-00087, -00088, -00089, -00090, -00091.
|